Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NeoRecormon in Anemic Breast Cancer Patients
NCT02761642Phase 2Completed
- Sponsor
- Roche
- Start
- Feb 2004
- Primary completion
- Mar 2007
- Modality
- Erythropoietins, Colony Stimulating Factors
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of epoetin beta in anemia, sponsored by Roche. Primary endpoint: Percentage of Participants With Response to Treatment Based on Hemoglobin Levels at 12 weeks. Started Feb 2004; status: completed.
02
Drugs
epoetin beta
03
Conditions
anemia
Beyond the preview
Go deeper on NCT02761642.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02761642.